Plain-English translation of NCT07329231 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a diet based on quinoa—a nutritious grain—can help people with early-stage type 2 diabetes better control their blood sugar and improve how their body uses insulin. Researchers will compare people who eat quinoa-based foods (like noodles, flour, and biscuits) as replacements for regular starchy foods with people who eat a standard diet. The goal is to see if this dietary change can reduce blood sugar fluctuations, improve cholesterol and triglyceride levels, and potentially decrease the need for diabetes medications.
Many people with newly diagnosed type 2 diabetes want to manage their condition through diet and lifestyle rather than medications alone. This trial exists to test whether quinoa, which has a different nutritional profile than regular grains, might be particularly helpful for stabilizing blood sugar and reducing insulin resistance in people early in their diabetes journey.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either eat quinoa-based foods (replacing your usual grains with quinoa noodles, flour, and biscuits for 14 weeks) or continue your regular diet. Both groups will receive nutrition and exercise counseling. You'll have blood tests and continuous glucose monitoring at the beginning and end of the study, and you'll attend monthly follow-up visits where researchers will check your blood sugar, blood lipids, and how well your insulin is working. You'll also keep a daily food diary documenting what you eat.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
China